Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth vs Franklin India Technology Fund-Growth

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

Based on the provided metrics, Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth appears stronger due to its higher returns across all timeframes, notably a 1Y return of 19.04% and a 3Y CAGR of 21.72%, compared to Franklin India Technology Fund-Growth's negative 1Y return of -5.8%. However, Franklin India Technology Fund has a higher star rating of 5 compared to Aditya Birla's 3, indicating a better overall assessment by analysts, albeit with a higher expense ratio of 1.16%. Investors should consider the tradeoff between Aditya Birla's superior returns and Franklin's higher rating when making their choice.

Aditya Birla Sun Life Mutual Fund

Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth

Aditya Birla Sun Life Mutual Fund

★★★★★

Equity · Sectoral

Franklin Templeton Mutual Fund

Franklin India Technology Fund-Growth

Franklin Templeton Mutual Fund

★★★★★

Equity · Sectoral

Metric Aditya Birla Sun Life ... Franklin India Technol...
NAV ₹40.76 ₹544.36
Star Rating ★★★ ★★★★★
Expense Ratio 1.04% 1.16%
AUM ₹1,077 Cr ₹1,742 Cr
1M Return +3.11% +5.45%
3M Return +0.32% -0.29%
6M Return +12.07% +13.03%
1Y Return +19.04% -5.8%
3Y CAGR +21.72% +10.29%
5Y CAGR +15.52% +7.22%
Risk Level — —
Fund Manager Dhaval Shah Anand Radhakrishnan, Srikesh Nair, Varun Sharma